Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

被引:24
作者
Bulk, Etmar [1 ,2 ]
Yu, Jun [1 ,3 ]
Hascher, Antje [1 ]
Koschmieder, Steffen [1 ]
Wiewrodt, Rainer [1 ]
Krug, Utz [1 ]
Timmermann, Bernd [4 ]
Marra, Alessandro [5 ]
Hillejan, Ludger [5 ]
Wiebe, Karsten [6 ]
Berdel, Wolfgang E. [1 ]
Schwab, Albrecht [2 ]
Mueller-Tidow, Carsten [1 ]
机构
[1] Univ Munster, Dept Med Hematol A, Munster, Germany
[2] Univ Munster, Inst Physiol 2, Munster, Germany
[3] Fourth Mil Med Univ, Sch Basic Med Sci, Ctr Teaching Expt, Xian 710032, Shaanxi, Peoples R China
[4] Max Planck Inst Mol Genet, D-14195 Berlin, Germany
[5] Niels Stensen Hosp Ostercappeln, Dept Thorac Surg, Ostercappeln, Germany
[6] Univ Munster, Dept Thorac Surg, Munster, Germany
关键词
BREAST-CARCINOMA CELLS; SOMATIC MUTATIONS; GENE-EXPRESSION; INVASIVENESS; PROMOTER; EPHRINS; EFNB2; STAGE; TRKA;
D O I
10.1371/journal.pone.0044591
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alterations of Eph receptor tyrosine kinases are frequent events in human cancers. Genetic variations of EPHB6 have been described but the functional outcome of these alterations is unknown. The current study was conducted to screen for the occurrence and to identify functional consequences of EPHB6 mutations in non-small cell lung cancer. Here, we sequenced the entire coding region of EPHB6 in 80 non-small cell lung cancer patients and 3 tumor cell lines. Three potentially relevant mutations were identified in primary patient samples of NSCLC patients (3.8%). Two point mutations led to instable proteins. An in frame deletion mutation (del915-917) showed enhanced migration and accelerated wound healing in vitro. Furthermore, the del915-917 mutation increased the metastatic capability of NSCLC cells in an in vivo mouse model. Our results suggest that EPHB6 mutations promote metastasis in a subset of patients with non-small cell lung cancer.
引用
收藏
页数:9
相关论文
共 31 条
[1]   Role of Tyrosine Kinase Inhibitors in Lung Cancer [J].
Ansari, J. ;
Palmer, D. H. ;
Rea, D. W. ;
Hussain, S. A. .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (05) :569-575
[2]   Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma [J].
Balakrishnan, Asha ;
Bleeker, Fonnet E. ;
Lamba, Simona ;
Rodolfo, Monica ;
Daniotti, Maria ;
Scarpa, Aldo ;
van Tilborg, Angela A. ;
Leenstra, Sieger ;
Zanon, Carlo ;
Bardelli, Alberto .
CANCER RESEARCH, 2007, 67 (08) :3545-3550
[3]  
Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61
[4]  
Castano J, 2008, HISTOL HISTOPATHOL, V23, P1011, DOI 10.14670/HH-23.1011
[5]   Somatic mutations affect key pathways in lung adenocarcinoma [J].
Ding, Li ;
Getz, Gad ;
Wheeler, David A. ;
Mardis, Elaine R. ;
McLellan, Michael D. ;
Cibulskis, Kristian ;
Sougnez, Carrie ;
Greulich, Heidi ;
Muzny, Donna M. ;
Morgan, Margaret B. ;
Fulton, Lucinda ;
Fulton, Robert S. ;
Zhang, Qunyuan ;
Wendl, Michael C. ;
Lawrence, Michael S. ;
Larson, David E. ;
Chen, Ken ;
Dooling, David J. ;
Sabo, Aniko ;
Hawes, Alicia C. ;
Shen, Hua ;
Jhangiani, Shalini N. ;
Lewis, Lora R. ;
Hall, Otis ;
Zhu, Yiming ;
Mathew, Tittu ;
Ren, Yanru ;
Yao, Jiqiang ;
Scherer, Steven E. ;
Clerc, Kerstin ;
Metcalf, Ginger A. ;
Ng, Brian ;
Milosavljevic, Aleksandar ;
Gonzalez-Garay, Manuel L. ;
Osborne, John R. ;
Meyer, Rick ;
Shi, Xiaoqi ;
Tang, Yuzhu ;
Koboldt, Daniel C. ;
Lin, Ling ;
Abbott, Rachel ;
Miner, Tracie L. ;
Pohl, Craig ;
Fewell, Ginger ;
Haipek, Carrie ;
Schmidt, Heather ;
Dunford-Shore, Brian H. ;
Kraja, Aldi ;
Crosby, Seth D. ;
Sawyer, Christopher S. .
NATURE, 2008, 455 (7216) :1069-1075
[6]  
Flanagan JG, 1997, CELL, V90, P403
[7]   EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells [J].
Fox, B. P. ;
Kandpal, R. P. .
ONCOGENE, 2009, 28 (14) :1706-1713
[8]   Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR [J].
Fox, BP ;
Kandpal, RP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (01) :268-276
[9]   Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application [J].
Fox, BP ;
Kandpal, RP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (04) :882-892
[10]   Patterns of somatic mutation in human cancer genomes [J].
Greenman, Christopher ;
Stephens, Philip ;
Smith, Raffaella ;
Dalgliesh, Gillian L. ;
Hunter, Christopher ;
Bignell, Graham ;
Davies, Helen ;
Teague, Jon ;
Butler, Adam ;
Edkins, Sarah ;
O'Meara, Sarah ;
Vastrik, Imre ;
Schmidt, Esther E. ;
Avis, Tim ;
Barthorpe, Syd ;
Bhamra, Gurpreet ;
Buck, Gemma ;
Choudhury, Bhudipa ;
Clements, Jody ;
Cole, Jennifer ;
Dicks, Ed ;
Forbes, Simon ;
Gray, Kris ;
Halliday, Kelly ;
Harrison, Rachel ;
Hills, Katy ;
Hinton, Jon ;
Jenkinson, Andy ;
Jones, David ;
Menzies, Andy ;
Mironenko, Tatiana ;
Perry, Janet ;
Raine, Keiran ;
Richardson, Dave ;
Shepherd, Rebecca ;
Small, Alexandra ;
Tofts, Calli ;
Varian, Jennifer ;
Webb, Tony ;
West, Sofie ;
Widaa, Sara ;
Yates, Andy ;
Cahill, Daniel P. ;
Louis, David N. ;
Goldstraw, Peter ;
Nicholson, Andrew G. ;
Brasseur, Francis ;
Looijenga, Leendert ;
Weber, Barbara L. ;
Chiew, Yoke-Eng .
NATURE, 2007, 446 (7132) :153-158